Kudelka A P, Termrungruanglert W, Vadhan-Raj S, Edwards C L, Varma D G, Tornos C, Verschraegen C F, Kavanagh J J
University of Texas MD Anderson Cancer Center, Houston 77030, USA.
Anticancer Drugs. 1996 Nov;7(8):885-9. doi: 10.1097/00001813-199611000-00011.
A patient who had a high-grade uterine leiomyosarcoma (LMS) with extensive intra-abdominal and pulmonary metastases at the time of diagnosis underwent supracervical hysterectomy, bilateral salpingo-oophorectomy and tumor reductive surgery. She then received induction chemotherapy with paclitaxel 135 mg/m2 over 24 h and carboplatin (target AUC = 7.5 mg.ml/min) monthly for seven courses, achieving remission with a small amount of residual disease. The treatment was well tolerated except for peripheral neuropathy. Accordingly, the combination of carboplatin and paclitaxel may be considered in patients with advanced high-grade LMS of the uterus, and this regimen warrants further study in this disease.